Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07070830 · ClinicalTrials.gov registry record · NA
Simplified Onboarding in Adults With Type 2 Diabetes
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT07070830 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 56 participants.
The verdict
NCT07070830, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is an outpatient study testing different starting doses of insulin in participants with type 2 diabetes. Participants will manage their diabetes using the Omnipod M System. The system is comprised of an Omnipod M Pod, an Omnipod M Controller, and will be used with a Dexcom G6 continuous glucose monitoring sensor (CGM). The main objectives of the study are to evaluate the safety and tolerability of different starting doses of insulin using the Omnipod M System. There is a precursory evaluation before the main, randomized trial. Participation in the precursory evaluation could last up to 12 weeks and participation in the randomized trial could last up to 6 weeks. During both the evaluation and the randomized trial, participants will manage their diabetes using the Omnipod M System in Automated Mode. An optional 12-weeks of continued Omnipod M System use is available upon completion of the randomized trial.
Interventions
- DEVICE Active Comparator: Omnipod M System with lower starting dose
- DEVICE Active Comparator: Omnipod M System with higher starting dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2026-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07070830
The ClinicalTrials.gov registry entry for NCT07070830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Comparator: Omnipod M System with lower starting dose is the first listed.
NCT07070830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07070830 about?
NCT07070830 is a clinical study titled "Simplified Onboarding in Adults With Type 2 Diabetes". This is an outpatient study testing different starting doses of insulin in participants with type 2 diabetes. Participants will manage their diabetes using the Omnipod M System. The system is comprised of an Omnipod M Pod, an Omnipod M Controller, and will be used with a Dexcom G6 continuous glucose...
What is the current status of trial NCT07070830?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2025-07-18. Estimated completion is 2026-01-06.
What interventions are being tested in trial NCT07070830?
The interventions under investigation include: Active Comparator: Omnipod M System with lower starting dose (DEVICE), Active Comparator: Omnipod M System with higher starting dose (DEVICE).
Who is sponsoring clinical trial NCT07070830?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.